About 300,000 Australians live with glaucoma, which is why it’s a top priority for the ophthalmic community, with plenty of options to detect and treat this devastating eye disease.
Those tools include MIGS, first-line SLT treatment, preservative-free eye drops, miniaturised perimetry and a genetic test using saliva, which are among a host of relatively new options changing the glaucoma game.
But how do you make your product stand out in a competitive marketplace?
Insight’s March 2025 issue could be the answer, featuring a focus on what ophthalmologists and others can do to help stop the vicious cycle of poor mental health making a patient’s glaucoma worse.
This edition will dive into other topics as well, including the latest from RANZCO on the new Australian-developed saliva test for the eye disease and plenty of CPD, including how Dr Kenneth Ooi manages glaucoma as a refractive surgeon.
If you’re looking to reach ECPs specialising in glaucoma care this is a great opportunity to showcase your business/product to a highly engaged audience of ophthalmologists, optometrists and other eyecare professionals.
Expressions of interest close Tuesday 29 January 2025.
Limited positions available.
Luke Ronca, Insight brand manager
luke.ronca@primecreative.com.au or 0402 718 081
